None
Quote | BioVaxys Technology (OTCMKTS:LMNGF)
Last: | $0.239 |
---|---|
Change Percent: | -7.58% |
Open: | $0.2638 |
Close: | $0.239 |
High: | $0.2638 |
Low: | $0.2309 |
Volume: | 649,564 |
Last Trade Date Time: | 04/21/2021 03:05:41 pm |
News | BioVaxys Technology (OTCMKTS:LMNGF)
BioVaxys Announces New Chief Financial Officer Canada NewsWire VANCOUVER, BC , Sept. 8, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that Mr. Craig Loverock ha...
BioVaxys announces completed synthesis of its Pan-Sarbecovirus Vaccine candidate and launch of in vivo animal study Canada NewsWire VANCOUVER, BC , Sept. 6, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys...
Message Board Posts | BioVaxys Technology (OTCMKTS:LMNGF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
BioVaxys Technology Company Name:
LMNGF Stock Symbol:
OTCMKTS Market:
BioVaxys Announces New Chief Financial Officer Canada NewsWire VANCOUVER, BC , Sept. 8, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that Mr. Craig Loverock ha...
BioVaxys announces completed synthesis of its Pan-Sarbecovirus Vaccine candidate and launch of in vivo animal study Canada NewsWire VANCOUVER, BC , Sept. 6, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys...
BIOVAXYS ANNOUNCES COMPLETED DEBT SETTLEMENT Canada NewsWire VANCOUVER, B.C. , Aug. 2, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") further to its news release dated July 4, 2022 , Bi...